List of Tables
Table 1. Global Familial Amyloid Polyneuropathy Therapeutic Market Size Growth Rate by Drug Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Inotersen
Table 3. Key Players of Tafamidis
Table 4. Key Players of Patisiran
Table 5. Key Players of Others
Table 6. Global Familial Amyloid Polyneuropathy Therapeutic Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Familial Amyloid Polyneuropathy Therapeutic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Familial Amyloid Polyneuropathy Therapeutic Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Familial Amyloid Polyneuropathy Therapeutic Market Share by Region (2017-2022)
Table 10. Global Familial Amyloid Polyneuropathy Therapeutic Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Familial Amyloid Polyneuropathy Therapeutic Market Share by Region (2023-2028)
Table 12. Familial Amyloid Polyneuropathy Therapeutic Market Trends
Table 13. Familial Amyloid Polyneuropathy Therapeutic Market Drivers
Table 14. Familial Amyloid Polyneuropathy Therapeutic Market Challenges
Table 15. Familial Amyloid Polyneuropathy Therapeutic Market Restraints
Table 16. Global Familial Amyloid Polyneuropathy Therapeutic Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Familial Amyloid Polyneuropathy Therapeutic Market Share by Players (2017-2022)
Table 18. Global Top Familial Amyloid Polyneuropathy Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Familial Amyloid Polyneuropathy Therapeutic as of 2021)
Table 19. Ranking of Global Top Familial Amyloid Polyneuropathy Therapeutic Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Familial Amyloid Polyneuropathy Therapeutic Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Familial Amyloid Polyneuropathy Therapeutic Product Solution and Service
Table 23. Date of Enter into Familial Amyloid Polyneuropathy Therapeutic Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Familial Amyloid Polyneuropathy Therapeutic Market Size by Drug Type (2017-2022) & (US$ Million)
Table 26. Global Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share by Drug Type (2017-2022)
Table 27. Global Familial Amyloid Polyneuropathy Therapeutic Forecasted Market Size by Drug Type (2023-2028) & (US$ Million)
Table 28. Global Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share by Drug Type (2023-2028)
Table 29. Global Familial Amyloid Polyneuropathy Therapeutic Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share by Application (2017-2022)
Table 31. Global Familial Amyloid Polyneuropathy Therapeutic Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share by Application (2023-2028)
Table 33. North America Familial Amyloid Polyneuropathy Therapeutic Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Familial Amyloid Polyneuropathy Therapeutic Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Familial Amyloid Polyneuropathy Therapeutic Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Familial Amyloid Polyneuropathy Therapeutic Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Familial Amyloid Polyneuropathy Therapeutic Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Familial Amyloid Polyneuropathy Therapeutic Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Familial Amyloid Polyneuropathy Therapeutic Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Familial Amyloid Polyneuropathy Therapeutic Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Familial Amyloid Polyneuropathy Therapeutic Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Familial Amyloid Polyneuropathy Therapeutic Market Size by Country (2023-2028) & (US$ Million)
Table 43. Pfizer Inc. Company Detail
Table 44. Pfizer Inc. Business Overview
Table 45. Pfizer Inc. Familial Amyloid Polyneuropathy Therapeutic Product
Table 46. Pfizer Inc. Revenue in Familial Amyloid Polyneuropathy Therapeutic Business (2017-2022) & (US$ Million)
Table 47. Pfizer Inc. Recent Development
Table 48. Alnylam Pharmaceuticals Inc. Company Detail
Table 49. Alnylam Pharmaceuticals Inc. Business Overview
Table 50. Alnylam Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Product
Table 51. Alnylam Pharmaceuticals Inc. Revenue in Familial Amyloid Polyneuropathy Therapeutic Business (2017-2022) & (US$ Million)
Table 52. Alnylam Pharmaceuticals Inc. Recent Development
Table 53. Ionis Pharmaceuticals Inc. Company Detail
Table 54. Ionis Pharmaceuticals Inc. Business Overview
Table 55. Ionis Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Product
Table 56. Ionis Pharmaceuticals Inc. Revenue in Familial Amyloid Polyneuropathy Therapeutic Business (2017-2022) & (US$ Million)
Table 57. Ionis Pharmaceuticals Inc. Recent Development
Table 58. Corino Therapeutics Inc. Company Detail
Table 59. Corino Therapeutics Inc. Business Overview
Table 60. Corino Therapeutics Inc. Familial Amyloid Polyneuropathy Therapeutic Product
Table 61. Corino Therapeutics Inc. Revenue in Familial Amyloid Polyneuropathy Therapeutic Business (2017-2022) & (US$ Million)
Table 62. Corino Therapeutics Inc. Recent Development
Table 63. Proclara Biosciences Company Detail
Table 64. Proclara Biosciences Business Overview
Table 65. Proclara Biosciences Familial Amyloid Polyneuropathy Therapeutic Product
Table 66. Proclara Biosciences Revenue in Familial Amyloid Polyneuropathy Therapeutic Business (2017-2022) & (US$ Million)
Table 67. Proclara Biosciences Recent Development
Table 68. Arcturus Therapeutics Inc Company Detail
Table 69. Arcturus Therapeutics Inc Business Overview
Table 70. Arcturus Therapeutics Inc Familial Amyloid Polyneuropathy Therapeutic Product
Table 71. Arcturus Therapeutics Inc Revenue in Familial Amyloid Polyneuropathy Therapeutic Business (2017-2022) & (US$ Million)
Table 72. Arcturus Therapeutics Inc Recent Development
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Familial Amyloid Polyneuropathy Therapeutic Market Share by Drug Type: 2021 VS 2028
Figure 2. Inotersen Features
Figure 3. Tafamidis Features
Figure 4. Patisiran Features
Figure 5. Others Features
Figure 6. Global Familial Amyloid Polyneuropathy Therapeutic Market Share by Application in 2021 & 2028
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Others Case Studies
Figure 11. Familial Amyloid Polyneuropathy Therapeutic Report Years Considered
Figure 12. Global Familial Amyloid Polyneuropathy Therapeutic Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Familial Amyloid Polyneuropathy Therapeutic Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Familial Amyloid Polyneuropathy Therapeutic Market Share by Region: 2021 VS 2028
Figure 15. Global Familial Amyloid Polyneuropathy Therapeutic Market Share by Players in 2021
Figure 16. Global Top Familial Amyloid Polyneuropathy Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Familial Amyloid Polyneuropathy Therapeutic as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Familial Amyloid Polyneuropathy Therapeutic Revenue in 2021
Figure 18. North America Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Familial Amyloid Polyneuropathy Therapeutic Market Share by Country (2017-2028)
Figure 20. United States Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Familial Amyloid Polyneuropathy Therapeutic Market Share by Country (2017-2028)
Figure 24. Germany Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Familial Amyloid Polyneuropathy Therapeutic Market Share by Region (2017-2028)
Figure 32. China Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Familial Amyloid Polyneuropathy Therapeutic Market Share by Country (2017-2028)
Figure 40. Mexico Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Familial Amyloid Polyneuropathy Therapeutic Market Share by Country (2017-2028)
Figure 44. Turkey Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Pfizer Inc. Revenue Growth Rate in Familial Amyloid Polyneuropathy Therapeutic Business (2017-2022)
Figure 47. Alnylam Pharmaceuticals Inc. Revenue Growth Rate in Familial Amyloid Polyneuropathy Therapeutic Business (2017-2022)
Figure 48. Ionis Pharmaceuticals Inc. Revenue Growth Rate in Familial Amyloid Polyneuropathy Therapeutic Business (2017-2022)
Figure 49. Corino Therapeutics Inc. Revenue Growth Rate in Familial Amyloid Polyneuropathy Therapeutic Business (2017-2022)
Figure 50. Proclara Biosciences Revenue Growth Rate in Familial Amyloid Polyneuropathy Therapeutic Business (2017-2022)
Figure 51. Arcturus Therapeutics Inc Revenue Growth Rate in Familial Amyloid Polyneuropathy Therapeutic Business (2017-2022)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed